Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- Prior authorization reform is on the march. Next stop: House floor
- 7/24/2026 9:28:17 AM
- Statement attributable to: Willie Underwood, MD, MSc, MPH President, American Medical Association “Quick-moving legislation to reform prior authorization—adopted today by the House Energy and Commerce Committee—shows that this idea has bipartisan support and political legs.
- Implementing research priorities: webinar explores how global research agendas can lead to meaningful action
- 7/23/2026 9:25:23 AM
- On 16 June 2026, the World Health Organization (WHO) hosted the third webinar in its series on the Global Research Agenda on Knowledge Translation and Evidence-informed Policy-making, bringing together 138 participants from 48 countries to explore a critical but often overlooked question: what happens after a research agenda is published? While research agendas are …
- DRC: Over 180 children dead in Ebola outbreak as thousands need mental health support
- 7/23/2026 9:22:55 AM
- At least 189 children have died in the latest Ebola outbreak in eastern Democratic Republic of the Congo (DRC).[1] Thousands more are living with fear and trauma and in need of mental health support, Save the Children said.
- Can sports help improve motor skills in children with autism?
- 7/22/2026 9:22:19 AM
- Research suggests that more than half of children with autism spectrum disorder, a neurodevelopmental condition, experience motor impairments. An analysis in Developmental Medicine & Child Neurology indicates that sports-based interventions may improve motor skills in children with autism spectrum disorder, with martial arts and aquatic training demonstrating the most …
- Sanofi evolves its Executive Committee to support its next strategic chapter
- 7/21/2026 12:40:37 PM
- Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter.
- Emery Brown, Daniel Hastings, and Douglas Lauffenburger named Institute Professors
- 7/20/2026 1:41:55 PM
- A physician and neuroscientist who studies how anesthesia affects the brain; a leader in aerospace engineering, policy, and education; and the founding head of MIT’s Department of Biological Engineering have been awarded MIT’s highest faculty honor: the title of Institute Professor.
- MIT engineers find a precise way to grow artificial blood vessels
- 7/15/2026 9:44:33 AM
- Tissue engineers are finding ways to grow living organs and tissues from cells, with the aim of replacing diseased and damaged counterparts in the body.
- Elsevier Foundation and The Lancet Announce Winners of Inaugural Evidence to Impact Awards
- 7/15/2026 9:32:28 AM
- The Elsevier Foundation and The Lancet announced the three winning teams of the inaugural edition of The Lancet –Elsevier Foundation Evidence to Impact Awards.
- Can brain-computer interface training improve your ability to catch mistakes?
- 7/15/2026 9:22:26 AM
- The brain uses visual cues to coordinate muscle movement. When the motor commands and sensory feedback are out of alignment, visuo-motor errors occur.
- Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
- 7/10/2026 10:38:39 AM
- • Sarclisa Escena administered via the CirCLIQ ® on-body injector (OBI) offers a treatment experience designed with patients and HCPs in mind • The first anticancer treatment to be administered through an OBI, and the first MM treatment available by both SC OBI and manual SC administration in the US • Efficacy of Sarclisa now available in SC formulation with innovative …
- Could an investigational drug that targets DNA damage help treat Alzheimer’s disease?
- 7/10/2026 9:58:08 AM
- Using a mouse model of Alzheimer’s disease, investigators found that treatment with KCL-286, a molecule that activates the retinoic acid receptor-β (RARβ), enhanced the repair of DNA damage in neurons.
- Wiley Launches Advanced Immunology to Deepen Understanding of the Immune System in Health and Disease
- 7/9/2026 12:04:23 PM
- Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced the launch of Advanced Immunology, a new open access journal designed to connect basic science and clinical discovery across the immune system.
- Katalyze AI Raises $10.5M to Build the Agentic Operating System for Pharmaceutical Companies
- 7/6/2026 9:50:49 AM
- Katalyze AI, the agentic operating system for pharmaceutical companies, today announced $10.5 million in seed funding led by Bonfire Ventures, along with Inovia Capital, Ripple Ventures, Alumni Ventures, and leading angel investors including Gokul Rajaram and Farzad Soleimani.
- AMA modernizes maternity care coding to reflect today’s obstetric care
- 7/3/2026 11:59:08 AM
- The American Medical Association (AMA) is making the most significant update to maternity care coding in decades to reflect how pregnancy care is delivered and improve the data needed to advance maternal health.
- DePuy Synthes Appoints Christina Zamarro as Chief Financial Officer
- 7/3/2026 11:02:51 AM
- DePuy Synthes, a global leader in orthopaedic technologies and solutions, today announced the appointment of Christina Zamarro as Chief Financial Officer, DePuy Synthes, effective July 13, 2026.
- Availability of the aide-mémoire for Q2 2026 results
- 7/2/2026 10:41:05 AM
- Sanofi announced the availability of the aide-mémoire for Q2 2026 results on the “Investors” page of sanofi.com: Second quarter 2026 results Prepared each quarter, this document is intended to support financial modelling of the quarterly results.
- Enhertu approved in the EU as first tumour agnostic HER2-directed therapy and antibody drug conjugate for patients with previously treated HER2-positive metastatic solid tumours
- 7/2/2026 10:39:00 AM
- AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2-positive (immunohistochemistry [IHC] 3+) solid tumours who have received prior treatment and who have no satisfactory treatment options.
- Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study
- 6/30/2026 1:28:38 PM
- • Nexviazyme met its primary endpoint, participants alive and free of invasive ventilation, in treatment-naïve infants zero to six months of age in the Baby-COMET phase 3 study • Sanofi intends to submit the data to support a regulatory application in the US for the treatment of infantile-onset Pompe disease Positive results from the Baby-COMET phase 3, …
- Forty-ninth session of the FAO/WHO Codex Alimentarius Commission adopts new standards
- 6/29/2026 8:41:16 AM
- The 49th session of the Codex Alimentarius Commission (CAC49) will be held 6–10 July 2026 in Geneva, Switzerland. The plenary sessions will be webcast in all six UN languages (Arabic, Chinese, English, French, Russian and Spanish).
- Prior authorization reform gets promising start from House health panel
- 6/29/2026 8:04:05 AM
- Statement is attributable to: John Whyte, MD, MPH CEO, American Medical Association “The American Medical Association commends the House Energy and Commerce Health Subcommittee for its swift action today to advance the Improving Seniors’ Timely Access to Care Act.